Inclusion Criteria:  Give written informed consent; Be between 18 and 60 years of age inclusive; Have a body mass index <30 Kg/m2; Be in general good health, as determined by the investigator; Have a habitual dietary intake of ≥13g fibre/day; Self-reported consumption of a generally 'healthy diet'.  Exclusion Criteria:  Females who are pregnant, lactating or wish to become pregnant during the study; Participant has self-reported low-energy diet or other extreme dietary habits; Have experienced recurrent loose stool within the past 4 weeks; Recent gastroenteritis or food borne illness such as confirmed food poisoning within the past 4 weeks; Have taken a medication or dietary supplement that may influence GI activity within the 2-weeks prior to screening; Have a history of abdominal surgery (excluding appendectomy); Have taken anaesthesia within the past 4 weeks; Have a known or suspected food allergy or intolerance to any of the investigational product ingredients; Have taken antibiotics within the past 12-weeks; Have a recent history of drug and/or alcohol abuse at the time of enrolment; Are a smoker (defined as >5 cigarettes/week); Have made any major dietary change in the past 3 months; Have planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study; Have an active gastrointestinal disorder or previous gastrointestinal surgery; Have irritable bowel syndrome, diagnosed or undiagnosed and treated with chronic medications; Have a gastrointestinal disease i.e., chronic diarrhoea, Crohn's disease, ulcerative colitis, diverticulosis, stomach or duodenal ulcers, or with a history of such diseases; Have a metabolic or endocrine disorder such as diabetes, thyroidism, or other metabolic disorder; Have a severe chronic disease i.e. cancer, renal failure, hepatitis, HIV, cirrhosis etc., or with a history of such diseases; Are severely immunocompromised (HIV positive, transplant patient, on antirejection medications, on a systemic steroid for >30 days, or chemotherapy or radiotherapy within the last year); Have a personal history of anorexia nervosa, bulimia, or significant eating disorders; Experiences alarm features such as unintentional weight loss, rectal bleeding, recent change in bowel habit (<3 months) or abdominal pain; Participants who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial; Participant is currently receiving treatment involving experimental drugs. If the participant has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.